Femme et Homme
- | Pays :
- United Kingdom
- Germany
- Netherlands
- | Organes : -
- | Spécialités : -
Extrait
This study is designed as a proof of concept of AIN457 in patients with psoriatic arthritis. The study will address the evaluation of the efficacy at 6 and up to 24 weeks after two doses of AIN457 10 mg/kg administered three weeks apart.
Critère d'inclusion
- Psoriatic Arthritis